Psycheceutical Bioscience, Inc. (BWVI)
OTC
Closed
Oct 2, 2026
Day's Range
0.0005052 wk Range
0.000100Overview - BWVI - Psycheceutical Bioscience, Inc.
Key Statistics
Profitability
Profit Margin
‪0.00%‬
Operating Margin
‪0.00%‬
Ownership
Shares Outstanding
276.42M
Held by Insiders
‪0.00%‬
Held by Institutions
‪0.00%‬
Price stats
50-Day Avg
‪0.00044‬
200-Day Avg
‪0.00060‬
Dividends
Payout Ratio
‪0.00%‬
Shariah Compliance
Report Date: Feb 15, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - BWVI - Psycheceutical Bioscience, Inc.
Peers - BWVI - Psycheceutical Bioscience, Inc.
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on OTC.
- BWVIOTCPsycheceutical Bioscience, Inc.110.57KMarket Cap+75.00%52-week change—P/E (Trailing)‪0.00%‬Profit Margin
- MKGAFOTCMerck KGaA67.92BMarket Cap+9.27%52-week change25.32P/E (Trailing)‪11.21%‬Profit Margin
- MKKGYOTCMerck KGaA Sponsored ADR67.10BMarket Cap+8.97%52-week change24.90P/E (Trailing)‪11.21%‬Profit Margin
- GALDYOTCGalderma Group AG Unsponsored ADR45.20BMarket Cap+7.87%52-week change53.10P/E (Trailing)‪14.57%‬Profit Margin
- GDERFOTCGalderma Group AG44.15BMarket Cap+11.81%52-week change51.88P/E (Trailing)‪14.57%‬Profit Margin
- JHPCYOTCJiangsu Hengrui Pharmaceuticals Co. Ltd.43.14BMarket Cap-30.46%52-week change37.14P/E (Trailing)‪86.20%‬Profit Margin
- HLNCFOTCHaleon plc38.69BMarket Cap+1.79%52-week change18.58P/E (Trailing)‪14.55%‬Profit Margin
Profile Summary - BWVI - Psycheceutical Bioscience, Inc.
About
Psycheceutical Bioscience, Inc. is a pioneering company in the biopharmaceutical sector, focusing on the development of innovative psychedelic-based medications. Its primary function is to create advanced therapeutic solutions targeting neurological disorders and mental health conditions, leveraging the unique…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
